ACOG
Price
$6.28
Change
-$0.02 (-0.32%)
Updated
Feb 21 closing price
Capitalization
100.6M
BLTE
Price
$57.00
Change
-$0.25 (-0.44%)
Updated
Feb 21 closing price
Capitalization
1.83B
34 days until earnings call
Ad is loading...

ACOG vs BLTE

Header iconACOG vs BLTE Comparison
Open Charts ACOG vs BLTEBanner chart's image
Alpha Cognition
Price$6.28
Change-$0.02 (-0.32%)
Volume$67.49K
Capitalization100.6M
Belite Bio
Price$57.00
Change-$0.25 (-0.44%)
Volume$8.52K
Capitalization1.83B
ACOG vs BLTE Comparison Chart
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACOG vs. BLTE commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACOG is a Hold and BLTE is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (ACOG: $6.30 vs. BLTE: $57.25)
Brand notoriety: ACOG and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACOG: 189% vs. BLTE: 93%
Market capitalization -- ACOG: $100.6M vs. BLTE: $1.83B
ACOG [@Biotechnology] is valued at $100.6M. BLTE’s [@Biotechnology] market capitalization is $1.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACOG’s FA Score shows that 1 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • ACOG’s FA Score: 1 green, 4 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, ACOG is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 5 TA indicator(s) are bullish.

  • BLTE’s TA Score: 5 bullish, 3 bearish.

Price Growth

ACOG (@Biotechnology) experienced а +10.14% price change this week, while BLTE (@Biotechnology) price change was +1.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

BLTE is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.83B) has a higher market cap than ACOG($101M). ACOG YTD gains are higher at: 6.961 vs. BLTE (-9.271). ACOG has higher annual earnings (EBITDA): -14.46M vs. BLTE (-35.42M). ACOG (0) and BLTE (0) have equivalent revenues.
ACOGBLTEACOG / BLTE
Capitalization101M1.83B6%
EBITDA-14.46M-35.42M41%
Gain YTD6.961-9.271-75%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.67MN/A-
Total Debt2.21MN/A-
TECHNICAL ANALYSIS
Technical Analysis
BLTE
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
67%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
68%
View a ticker or compare two or three
Ad is loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HCAYX57.16N/A
N/A
Hartford Capital Appreciation Y
OFALX18.77N/A
N/A
Olstein All Cap Value C
MSCMX16.42N/A
N/A
Morgan Stanley Insight C
VYMQX19.08N/A
N/A
Voya Mid Cap Research Enhanced Index A
BILSX9.66N/A
N/A
BlackRock U.S. Insights Lon/Shr Eq Ins

ACOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACOG has been loosely correlated with VRCA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ACOG jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACOG
1D Price
Change %
ACOG100%
-3.67%
VRCA - ACOG
34%
Loosely correlated
+0.26%
BLTE - ACOG
26%
Poorly correlated
+0.76%
IPHA - ACOG
24%
Poorly correlated
+2.96%
CDIO - ACOG
21%
Poorly correlated
-19.49%
SNDX - ACOG
21%
Poorly correlated
+8.41%
More

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+0.76%
RAIN - BLTE
48%
Loosely correlated
+1.25%
ELVN - BLTE
27%
Poorly correlated
-1.96%
ALEC - BLTE
24%
Poorly correlated
+1.64%
ACOG - BLTE
24%
Poorly correlated
-3.67%
PDSB - BLTE
23%
Poorly correlated
-2.07%
More